Santarus’ CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)

Our third product is Fenoglide. It’s a fenofibrate product. We licensed this product from Cowen Royalty. They had — actually the product had been with Sciele. When they got purchased by Shionogi, the product went back to Cowen Royalty and we licensed it …

Posted in Uncategorized

Santarus’ CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)

Our third product is Fenoglide. It’s a fenofibrate product. We licensed this product from Cowen Royalty. They had — actually the product had been with Sciele. When they got purchased by Shionogi, the product went back to Cowen Royalty and we licensed it …

Posted in Uncategorized